Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Young William d, Director. Director active across 2 companies, notably Praxis Precision Medicines, Inc.. Aggregated, 2 filings have been recorded. History available since 13 May 2021. The latest transaction was filed on 26 April 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Young William D is a Director at Praxis Precision Medicines, Inc. and Theravance Biopharma, Inc. In this role, he oversees the activities of these companies and participates in strategic decision-making. William is committed to promoting transparency and ensuring that shareholder interests are considered in all decisions.